Page 7 - ஒன்றுபட்டது மாநிலங்களில் தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Key Capital Launches Unique Natural Mental Health Supplement
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Key Capital Launches Unique Natural Mental Health Supplement
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
The Scottish newspaper
The National described the party as “right-wing, pro-Brexit, anti-feminist,” and noted that the party’s leader Richard Lucas, “has defended comments comparing same-sex marriage to incest.”
Tanzer says that he identified as gay until the age of 32, but now says he is heterosexual and is in a relationship with a woman. On his Facebook page, he complains of what he calls “LGBT indoctrination… in school and in church.”
In another Facebook post, Tanzer says, “If you think EDUCATION should focus more on Math, Reading and Writing and less on LGBT, Black Lives Matter, and radical environmental activism, please like and share this message and consider voting for the Scottish Family Party.”
Editorial: Impacts of Covid could be around for the long haul
nzherald.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nzherald.co.nz Daily Mail and Mail on Sunday newspapers.
Genkyotex: Disclosure of the total number of voting rights and shares pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority
Regulatory News:
Genkyotex shares
Date
(1): 11,736,174
(2): 11,726,931
(1)
In accordance with Article 223-111 of the AMF s General Regulation, this number of shares is calculated based on all shares carrying the right to vote, including those stripped of voting rights.
(2)
About Genkyotex
Genkyotex is the leading biopharmaceutical company in NOX therapies, listed on the Euronext Paris and Euronext Brussels markets. Its unique platform enables the identification of orally available small-molecules which selectively inhibit specific NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. Genkyotex is developing a pipeline of first-in-class product candidates targeting